Back to search results

Palbociclib and Pembrolizumab In Central Nervous System Metastases

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Malignant Neoplasm to Brain · Recurrent Brain Metastases · Progressive Brain Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Priscilla Brastianos, MD) · PBRASTIANOS@mgh.harvard.edu · 617-724-8770
    Contact: Principal Investigator (Priscilla Brastianos, MD)

  • Dana Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Eudocia K. Lee, MD) · 617-632-2166
    Contact: Principal Investigator (Eudocia Lee, MD)
Study leads

  • Priscilla Brastianos, MD

    Principal Investigator

    Massachusetts General Hospital

View source on ClinicalTrials.gov(opens in a new tab)